Published in Osteoarthritis Cartilage on April 01, 2001
Tibiofemoral joint osteoarthritis: risk factors for MR-depicted fast cartilage loss over a 30-month period in the multicenter osteoarthritis study. Radiology (2009) 1.95
Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis (2005) 1.05
Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis. Arthritis Res Ther (2006) 1.04
Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis (2005) 1.01
Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management. Rheum Dis Clin North Am (2008) 0.99
Diet and exercise for obese adults with knee osteoarthritis. Clin Geriatr Med (2010) 0.93
Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the knee. Osteoarthritis Cartilage (2008) 0.88
Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritis. HSS J (2010) 0.87
Failure of serum transforming growth factor-beta (TGF-beta1) as a biomarker of radiographic osteoarthritis at the knee and hip: a cross-sectional analysis in the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage (2008) 0.85
Serum transforming growth factor-beta 1 is not a robust biomarker of incident and progressive radiographic osteoarthritis at the hip and knee: the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage (2010) 0.81
The potential value of blood biomarkers of intervertebral disk metabolism in the follow-up of patients with sciatica. Eur Spine J (2005) 0.79
Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease. J Orthop Res (2007) 0.78
[OVERLOAD of joints and its role in osteoarthritis. Towards understanding and preventing progression of primary osteoarthritis]. Z Rheumatol (2015) 0.75
Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest (1994) 3.30
Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials (1992) 3.10
Lysolecithin and cell fusion. Nature (1970) 2.90
Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest (2001) 2.90
Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J (1996) 2.89
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation (1999) 2.73
Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest (1995) 2.67
Bacillus subtilis genome project: cloning and sequencing of the 97 kb region from 325 degrees to 333 degrees. Mol Microbiol (1993) 2.49
Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. J Biol Chem (1985) 2.39
Medical interviewing by exemplary family physicians. J Fam Pract (1998) 2.34
Proteoglycans from bovine nasal cartilage. Properties of a soluble form of link protein. J Biol Chem (1979) 2.32
Aortic valve incompetence and replacement in rheumatoid arthritis. Ann Rheum Dis (1975) 2.23
Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest (1989) 2.20
Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum (1987) 2.19
Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest (1992) 2.10
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage (2011) 1.89
The role of soft connective tissue in the breakdown of pig articular cartilage cultivated in the presence of complement-sufficient antiserum to pig erythrocytes. II. Distribution of immunoglobulin G (IgG). Int Arch Allergy Appl Immunol (1973) 1.89
Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest (2001) 1.78
Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest (1995) 1.77
Proteoglycans in health and disease: structures and functions. Biochem J (1986) 1.75
Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest (1998) 1.66
Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum (1987) 1.66
Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage. Biochem J (1985) 1.62
An immunoelectron microscope study of the organization of proteoglycan monomer, link protein, and collagen in the matrix of articular cartilage. J Cell Biol (1982) 1.60
Localization of proteoglycan monomer and link protein in the matrix of bovine articular cartilage: An immunohistochemical study. J Histochem Cytochem (1980) 1.59
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum (1999) 1.59
Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum (2000) 1.57
The heterogeneity of link proteins isolated from human articular cartilage proteoglycan aggregates. J Biol Chem (1982) 1.50
Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med (1999) 1.49
Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum (2000) 1.47
Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature (1978) 1.47
Age-related changes in the structure of proteoglycan link proteins present in normal human articular cartilage. Biochem J (1983) 1.46
Pharmacokinetics of methotrexate after local tubal injection for conservative treatment of ectopic pregnancy. Fertil Steril (1992) 1.42
Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix (1993) 1.42
The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum (1987) 1.41
A study of 609 infertile couples: a comparison of Jewish and Arab patients. Isr J Med Sci (1995) 1.39
Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis. Electrophoresis (1998) 1.37
Identification of core protein, an intermediate in proteoglycan biosynthesis in cultured chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem (1981) 1.35
Characterization of a thiol proteinase secreted by malignant human breast tumours. Biochim Biophys Acta (1980) 1.33
An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage (2000) 1.29
Immunoinhibition of intracellular protein digestion in macrophages. J Exp Med (1973) 1.29
Association of an extracellular protein (chondrocalcin) with the calcification of cartilage in endochondral bone formation. J Cell Biol (1984) 1.28
Action of concanavalin A on the attachment stage of phagocytosis by macrophages. Exp Cell Res (1971) 1.28
Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest (1994) 1.27
Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues. J Histochem Cytochem (1986) 1.26
Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res (1980) 1.25
Role of proteoglycans in endochondral ossification: immunofluorescent localization of link protein and proteoglycan monomer in bovine fetal epiphyseal growth plate. J Cell Biol (1982) 1.25
Proteoglycans from bovine nasal cartilage. Immunochemical studies of link protein. J Biol Chem (1980) 1.24
Age-related changes in protein-related epitopes of human articular-cartilage proteoglycans. Biochem J (1986) 1.24
Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks. Behav Neurosci (1994) 1.24
Altered distribution of lysosomal cathepsin D in ischemic myocardium. J Clin Invest (1977) 1.21
The extracellular matrix of cartilage in the growth plate before and during calcification: changes in composition and degradation of type II collagen. Calcif Tissue Int (1992) 1.21
Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum (1984) 1.17
Lysosomal alterations in hypoxic and reoxygenated hearts. II. Immunohistochemical and biochemical changes in cathepsin D. Am J Pathol (1980) 1.17
Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum (1990) 1.17
The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell Immunol (1992) 1.17
Early post-traumatic osteoarthritis-like changes in human articular cartilage following rupture of the anterior cruciate ligament. Osteoarthritis Cartilage (2005) 1.16
Localisation of plasma alpha2HS glycoprotein in mineralising human bone. Nature (1975) 1.16
Isolation and characterization of a 35,000 molecular weight subunit fetal cartilage matrix protein. J Biol Chem (1983) 1.16
Cathepsin D in cartilage: the immunohistochemical demonstration of extracellular enzyme in normal and pathological conditions. J Cell Sci (1974) 1.15
Unsuitability of leucine naphthylamide for the histochemical demonstration of lysosomal proteolytic activity. Nature (1969) 1.15
Structural changes during development in bovine fetal epiphyseal cartilage. Coll Relat Res (1981) 1.15
Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum (2001) 1.14
Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthritis Cartilage (2001) 1.14
A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation. Dev Biol (1996) 1.13
The human lumbar endplate. Evidence of changes in biosynthesis and denaturation of the extracellular matrix with growth, maturation, aging, and degeneration. Spine (Phila Pa 1976) (1996) 1.12
Mammalian eyes and associated tissues contain molecules that are immunologically related to cartilage proteoglycan and link protein. J Cell Biol (1982) 1.12
Secretion and localization of cathepsin D in synovial tissues removed from rheumatoid and traumatized joints. An immunohistochemical study. Arthritis Rheum (1977) 1.11
Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population. Cell Immunol (1983) 1.11
Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage (2002) 1.11
The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis. Osteoarthritis Cartilage (2007) 1.10
Chondrogenesis in periosteal explants. An organ culture model for in vitro study. J Bone Joint Surg Am (1994) 1.10
Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice. Hum Mol Genet (2006) 1.09
First trimester diagnosis of conjoined twins in a triplet pregnancy after IVF and ICSI: case report. Hum Reprod (2000) 1.08
The immunocytochemical demonstration of cathepsin D. J Histochem Cytochem (1972) 1.07
Monoclonal antibodies to different protein-related epitopes of human articular cartilage proteoglycans. Biochem J (1986) 1.06
Ultrasound determination of fetal sex. Am J Obstet Gynecol (1981) 1.06
Isolation of proteoglycan-specific T lymphocytes from patients with ankylosing spondylitis. Cell Immunol (1988) 1.05
Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. J Orthop Res (1996) 1.05
Invasion of cartilage by an experimental rat tumor. Cancer Res (1970) 1.05
Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis. Arthritis Res Ther (2006) 1.04
Chondrocalcin is identical with the C-propeptide of type II procollagen. Biochem J (1986) 1.04
Detection of anticentromere antibodies using cloned autoantigen CENP-B. Arthritis Rheum (1987) 1.04
The identification and characterization of two populations of aggregating proteoglycans of high buoyant density isolated from post-natal human articular cartilages of different ages. Biochem J (1987) 1.04
Biochemical and immunological studies of lysosomal and related proteinases in health and disease. J Histochem Cytochem (1981) 1.03